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Abstract 
It is not only unclear why hallucinations in schizophrenia occur with different prevalence by 
modality, but also to what extent they do. Reliable prevalence estimates of hallucinations by 
modality in schizophrenia are currently lacking, particularly for non-auditory hallucinations. 
Studies have also tended to report lifetime, not point prevalence by modality. This study 
assessed the prevalence and co-occurrence of hallucinations, for both lifetime and point 
prevalence, across the auditory, visual, olfactory, and tactile modalities, in people diagnosed 
with chronic schizophrenia-spectrum disorders in Ireland (N=693) and Australia (N=218). 
Lifetime prevalence was 64-80% auditory, 23-31% visual, 9-19% tactile, and 6-10% 
olfactory. Past month prevalence was 23-27% auditory, 5-8% visual, 4-7% tactile, and 2% 
olfactory. The majority of participants had only hallucinated in one modality, with this nearly 
always being the auditory. Approximately one-third had hallucinated in two modalities, most 
commonly the auditory and visual. Most currently hallucinating patients also hallucinated in 
a single modality, again, nearly always the auditory. Whereas 30-37% of patients with 
lifetime auditory hallucinations had experienced visual hallucinations, 83-97% of patients 
with experience of visual hallucinations had experienced auditory hallucinations. These 
findings help delineate the modality distribution of hallucinations in schizophrenia, and 
provide an explanatory target for theoretical models. 
 
Keywords: Auditory; psychosis; olfactory; tactile; visual. 
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Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum 
disorders 
 
1. Introduction 
A major, and largely unaddressed, challenge for models of hallucinations in schizophrenia is 
to explain why hallucinations in different sensory modalities (e.g., the auditory, visual, 
olfactory, tactile) occur with differing prevalence. For example, models of hallucinations that 
propose source-monitoring deficits underpin the experience (e.g., Waters et al., 2012) do not 
predict that such deficits would preferentially attach to some modalities of perception rather 
than others. Hallucinations in the auditory modality are well-understood to be “by far the 
most common” (APA, 2013, p.300) and have been consistently found to exceed the 
prevalence of visual hallucinations (Jablensky, 1997; Bowman and Raymond, 1931; WHO, 
1975; Thomas et al., 2007). The latter, in turn, have been found to occur with greater 
prevalence than hallucinations in the tactile and olfactory modalities (Thomas et al., 2007). 
Despite this apparent consensus over the hierarchy of hallucinations, there has been a lack of 
rigorous research into the prevalence of non-auditory hallucinations (Gauntlett-Gilbert and 
Kuipers, 2003; Langdon et al., 2011). For example, a recent review found a mean prevalence 
of visual hallucinations in schizophrenia of 27%, but noted significant variation between 
studies, with prevalence estimates varying from 4%-65% (Waters et al., 2014). This variation 
may have reflected cultural differences, a reliance on small sample sizes, and the use of both 
standardised and non-standardised assessment methods (Waters et al., 2014). Given this 
situation, the first aim of our study was to obtain a more reliable estimate of the lifetime 
prevalence of different modalities of hallucinations in schizophrenia. This was to be achieved 
by employing large samples, in two different countries, using standardised assessment 
measures.  
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 Studies rarely report both lifetime and point prevalence of hallucination by modality, 
which has the potential to be misleading. For example, it has been suggested that visual 
hallucinations are often experienced infrequently (Gauntlett-Gilbert and Kuipers, 2003) 
meaning lifetime prevalence estimates may give a misleading, inflated impression of 
ubiquity. Furthermore, there is some suggestion that the hierarchy of hallucinations 
documented for lifetime prevalence of hallucinations in schizophrenia may not be mirrored 
for point prevalence. For example, Langdon et al. (2011) reported on the prevalence of 
hallucinations by modality in the past month (determined from interview-based assessments) 
in two large samples of people diagnosed with chronic schizophrenia-spectrum disorders. 
Auditory hallucinations were overwhelmingly the most prevalent modality of hallucination 
(50-57%). However, it was found that tactile hallucinations (28%), occurred at comparable 
levels to visual hallucinations (23-26%), with olfactory hallucinations (13-17%) occurring 
with lower prevalence. This finding of a comparable prevalence of current visual and tactile 
hallucinations was not without precedent (Baethge et al., 2005). Another study, which used 
an experience sampling methodology, found that current prevalence of visual hallucinations 
was higher than that of auditory hallucinations (Delespaul and van Os, 2002). Over the course 
of a week, 63% of patients reported visual hallucinations, but only 49% reported auditory 
hallucinations. However, this used a liberal criterion for the presence of hallucinations, and 
when more stringent criteria were employed by Oorschot et al. (2012) the more expected 
current rate of auditory hallucinations (34%) and visual hallucinations (26%) was found. In 
order to contribute further data pertaining to the nature of the hallucination-hierarchy in 
schizophrenia by point prevalence, the second aim of our study was to report point 
prevalence (past month) of hallucinations by modality. 
In addition to lifetime and point prevalence by modality, it is not clear the extent to 
which different modalities of hallucinations co-occur (Oorschot et al., 2012), both over the 
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lifetime as well as in the past month. Preliminary evidence suggests that patients with visual 
hallucinations are highly likely to also have auditory hallucinations. The experience sampling 
study of Oorschot et al. found 79% of patients with visual hallucinations also had auditory 
hallucinations, and an interview-based study by Mueser et al. (1990) reported an equivalent 
figure of 84%. In contrast, those with auditory hallucinations are much less likely to have 
other forms of hallucinations. For example, Nayani and David (1996) found only 51% of 
people diagnosed with schizophrenia with auditory hallucinations reported visual 
hallucinations, and that these experiences of visual hallucinations were often rare and 
transitory. Oorschot et al.’s ESM study found that only 40% of patients with auditory 
hallucinations also reported visual hallucinations. Additional data concerning this question is 
required. People diagnosed with psychosis who experience visual hallucinations in the 
absence of auditory hallucinations may imply, at least in some people, separate and 
independent causation of their visual hallucinations. For example, visual hallucinations in 
neurodegenerative disorders (e.g., Lewy Body Dementia and Parkinson’s disease) are not 
related to the presence of auditory hallucinations and are thought to arise from a combination 
of impaired visual perception and attentional deficits (Collerton et al., 2005). Thus, the third 
aim of our study was to examine how different modalities of hallucinations co-occur over the 
course of a lifetime, as well as contemporaneously. 
Finally, given the aforementioned relative paucity of visual hallucinations research in 
samples of people diagnosed with schizophrenia (Gauntlett-Gilbert and Kuipers, 2003), we 
were also interested to record instances of the content of visual hallucinations experienced by 
such patients (Dudley et al., 2013), and to examine the relation between visual hallucinations 
and demographic factors. For example, in participants under 60 years of age, visual 
hallucinations presence has been found to be inversely related to age (Bauer et al., 2011). In 
terms of gender, women are more likely than men to experience hallucinations (Baethge et 
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al., 2005), but it is not clear if this is true for visual hallucinations specifically (Waters et al., 
2014). 
In summary, the present study aimed to document the prevalence and co-occurrence 
of hallucinations across the auditory, visual, olfactory, and tactile modalities, in terms of both 
lifetime and point prevalence, using a standardised assessment in two large, distinct samples 
of people (one drawn from Ireland, the other from Australia) who had formally been 
diagnosed with schizophrenia-spectrum disorders.  
 
2. Methods  
2.1 Participants 
Ireland. Participants were 613 people with schizophrenia-spectrum diagnoses 
(schizophrenia, schizoaffective disorder, schizophreniform disorder), recruited from 
psychosis services across Ireland, for whom complete hallucination data was available. 
Clinical assessments were carried out by either a Psychiatric Research Fellow, or 
dedicated research nurses trained in the administration of the diagnostic interview test 
instruments, working under supervision. Demographic and clinical information is reported in 
Table 1. DSM-IV diagnosis was determined using the Structured Clinical Interview for DSM-
IV Axis 1 Diagnoses (First et al., 2002). Exclusion criteria were that participants had a 
history of comorbid psychiatric disorder, substance abuse in the preceding 6 months, or prior 
head injury with loss of consciousness. While data have been reported previously on a subset 
of this sample (e.g., Corvin et al., 2008), all analyses reported here are novel. 
Australia. Participants were 218 people with schizophrenia-spectrum diagnoses, 
recruited from psychosis services across Australia (Loughland et al., 2010), who had a 
complete response set for the hallucinations section of the Diagnostic Interview for Psychosis 
(DIP; Castle et al., 2006). Clinical assessments were performed by registered psychologists or 
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intern psychologists, trained in the administration of the diagnostic interview test instruments, 
working under supervision. DSM-IV (APA, 1994) diagnosis was determined using the DIP. 
Exclusion criteria included an inability to converse fluently in English, organic brain 
disorder, brain injury with post-traumatic amnesia >24 h, intellectual disability (IQ<70), 
current diagnosis of substance dependence, and electroconvulsive therapy received in the last 
6 months. While data have been reported previously on subset of this sample (Loughland et 
al., 2010), the analyses reported here are novel.  
2.2 Measures 
Ireland. The presence of hallucinations was assessed using the Scale for the 
Assessment of Positive Symptoms (SAPS; Andreasen, 1984). All participants were assessed 
for current experience (present in the previous month) of hallucinations, and a subset (n=205) 
were also assessed for lifetime experiences of hallucinations. The SAPS inquires about 
hallucinations in the auditory, visual, tactile, and olfactory modalities (Auditory: “Have you 
ever heard voices or other sounds when no one is around?” Visual “Have you had visions or 
seen things that other people cannot?” Olfactory: “Have you ever experienced any unusual 
smells or smells that others do not notice?” Tactile: “Have you ever had burning sensations 
or other strange feelings in your body? Did your body ever appear to change in shape or 
size?”). All hallucination items are rated on a 0-5 scale (0 = absent; 1 = questionable; 2 = 
mild, occur only occasionally; 3 = moderate, have occurred at least weekly; 4 = marked, 
occur almost every day; 5 = severe, occur often every day). There is variability in what cut-
off score researchers use to determine the presence of hallucinations. Studies have variously 
defined the presence of hallucinations as being indicated by a score of ≥1 (e.g., Ford et al., 
2009), ≥2 (e.g., Andreasen and Flaum, 1991; David et al., 2011), ≥3 (e.g., Alba-Ferrara et al., 
2007; Andreasen and Flaum, 1991), or ≥4 for “prominent hallucinations” (Andreasen and 
Flaum, 1991). Our approach was to report the full distribution of SAPS hallucination scores 
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in Supplemental Table 1, to allow the reader to make their own determinations, and to use a 
score of ≥3 as the criterion for the presence of hallucinations in the analyses presented here. 
This decision ensured that normative, fleeting hallucinatory experiences were not included in 
our data (e.g., Johns et al., 2004; Krakvik et al., 2015) and also maximised the comparability 
of the SAPS data with the measure of hallucinations employed in the Australian sample (see 
below). 
Australia. All participants were assessed for both lifetime and current (experienced in 
the last month) experience of hallucinations in the auditory, visual, tactile, and olfactory 
modalities using the hallucinations section of the DIP. This enquires about the presence of 
each modality of hallucinations separately (Auditory: “Have you ever heard noises or voices 
when there is nobody about and no ordinary explanation seems possible?” Visual: “Have you 
ever had visions or seen things that other people cannot?” Olfactory: “Have you ever noticed 
unusual smells you cannot account for? (rate experiences such as smell of ‘death’ or 
burning, which other people cannot smell). Tactile: “Have you ever experienced any strange 
sensations in your body, e.g. of touch, or temperature, or pain, or floating, or being 
weightless? Or a crawling sensation under the skin?”). Participants who give affirmative 
responses to any of these items are then rated according to whether the hallucination had been 
a) “Present for less than 1 month or unspecified”, or b) “Present for significant proportion of 
a 1-month period”. Only those with hallucinations meeting criterion b) were defined as 
having hallucinations, as the broadness of criterion a) could potentially have led to the 
inclusion of false positives (potentially akin to the ‘questionable’ rating on the SAPS) or 
normative fleeting hallucinatory experiences (potentially akin to the ‘mild’ rating on the 
SAPS). Full frequency data for DIP hallucination scores by modality are presented in 
Supplemental Table 2. 
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2.3  Statistical analyses 
Descriptive data on hallucination prevalence and co-occurrence by modality were to be 
presented, separately for the Irish and Australian samples, in the form of percentages. We did 
not perform between-country comparisons on hallucination prevalence owing to the different 
assessment tools used in these populations making direct comparisons problematic, as well as 
the large number of actual and potential differences between the two groups making it 
impossible to determine what may account for any differences. First, significant differences 
were found between the two groups on age, gender, duration of illness, and diagnoses. 
Second, differing exclusion criteria were employed for each sample. Third, there are greater 
levels of use of substances with potentially hallucinogenic sequalae in Australia compared to 
Ireland, including LSD (Entwistle et al., 2016) and alcohol (WHO, 2016). Finally, there was 
the potential for different diagnostic and prescribing practices for between these countries. 
We used binary logistic regression to test if gender and age predicted experience of 
hallucinations in each modality, entering both these variables in a single step. Chi squared 
tests were to be used to test for associations between the lifetime presence of auditory and 
visual hallucinations. All analyses were to be performed using two-tailed tests with α=.05. 
 
3. Results 
Demographic and clinical information is reported in Table 1.  
INSERT-TABLE-1-ABOUT-HERE 
3.1 Lifetime prevalence  
Ireland. Of the 693 people with schizophrenia-spectrum diagnoses, 69.3% had 
hallucinated in at least one of the modalities enquired about at some point in their lifetime 
(Table 2). Many hallucinations had religious themes. Patients’ auditory hallucinations 
included hearing devils marching from hell over stones coming to get them, a choir of 
  HALLUCINATIONS IN SCHIZOPHRENIA      11 
 
demonic voices, the Devil telling them to burn down the house and go to the pub, and voices 
saying “the next time you see him he’ll be half dead”, “let her have her day in court”, “get up 
whore”, “keep going, keep going man”. Visual hallucinations included seeing people change 
into vampires, hell, flames, rats, people’s eyes gone black, wisps of smoke, ugly faces, 
Christ’s face, the Virgin Mary, and visions of Calvary. Tactile hallucinations included 
sensations in the mouth, energies around their body, being poked gently, and a multimodal 
experience of feeling ash in the throat whilst seeing hell. Olfactory hallucinations included 
smelling a brewery, burning rubber, sewage, roses, perfume, and themselves burning. 
Patients were most likely to have lifetime experience of auditory hallucinations, with 
this type of hallucination being approximately three times as common as visual 
hallucinations, which were in turn around twice as common as tactile hallucinations, which in 
turn were approximately twice as prevalence as olfactory hallucinations (Table 2). Binary 
logistic regression found age and gender did not significantly predict lifetime experience of 
hallucinations in the auditory, χ2(2)=1.53, p=.47, visual, χ2(2)=0.31, p=.86, tactile, 
χ2(2)=3.20, p=.20, or olfactory, χ2(2)=0.10, p=.95, modalities.  
INSERT-TABLE-2-ABOUT-HERE 
Australia. Of the 218 people with schizophrenia-spectrum diagnoses, 81.7% had 
hallucinated in at least one of the modalities enquired about at some point in their lifetime 
(Table 2). Auditory hallucinations were more than twice as common as visual hallucinations, 
which were in turn three times as common as olfactory hallucinations and fifty percent more 
common than tactile hallucinations. This pattern broadly mirrored that from the Irish sample. 
Binary logistic regression found that age and gender did not predict lifetime experience of 
hallucination in any modality: auditory, χ2(2)=5.22, p=.07; visual, χ2(2)=4.99, p=.08, 
olfactory, χ2(2)=2.02, p=.36; tactile, χ2(2)=1.93, p=.38. 
 
  HALLUCINATIONS IN SCHIZOPHRENIA      12 
 
3.2 Point prevalence 
Ireland. Although a quarter of patients had current hallucinations, these were 
predominantly in the auditory modality, with prevalence of current hallucinations in other 
modalities all being less than 5% (Table 2). Binary logistic regression found that age and 
gender did not predict current presence of auditory, χ2(2)=1.98, p=.37, visual, χ2(2)=1.42, 
p=.49, olfactory, χ2(2)=1.46, p=.48, or tactile hallucinations, χ2(2)=1.65, p=.44. 
Australia. As with the Irish sample, approximately a quarter of patients had some 
current hallucinations (Table 2). Again, these were primarily in the auditory modality. Binary 
logistic regression found that age and gender did not significantly predict the presence of 
current hallucinations in any modality; auditory, χ2(2)=2.97, p=.23; visual, χ2(2)=2.92, p=.23; 
olfactory, χ2(2)=1.76, p=.42; tactile, χ2(2)=1.22, p=.54. 
 
3.3 Ratio of lifetime to current hallucinations. 
The proportion of patients with lifetime hallucinations who were currently hallucinating was 
broadly comparable for each modality, in both the Irish and Australian samples, being 34-
36% in the auditory, 20-27% in the visual, 24-28% in the olfactory, and 36-40% in the tactile. 
 
3.4 Co-occurrence of modalities 
The majority of patients in both samples had only ever hallucinated in one modality, and this 
was most commonly the auditory (Table 3). Around a third of patients in both samples had 
experienced hallucinations in two modalities, with the most common combination being the 
auditory and visual (Table 3). Only a single digit percentage of patients had hallucinated in 
three modalities, with a similar result being found for four modalities (Table 3). 
The majority of currently hallucinating patients were only hallucinating in one 
modality, nearly always the auditory (Table 4). The most common combination of 
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hallucinations in those who were currently experiencing hallucinations in two modalities was 
the auditory and visual (Table 4). Rates of current hallucinations in 3 or more modalities were 
very low (Table 4). The pattern of current hallucinations by modality for the Irish sample is 
presented in Figure 1. 
INSERT-TABLES-3-AND-4-ABOUT-HERE 
INSERT-FIGURE-1-ABOUT-HERE 
 In both samples there was an association between the lifetime presence of auditory 
and visual hallucinations (Table 5). It was more common to have experienced auditory 
hallucinations without ever having had visual hallucinations, than it was to have experienced 
visual hallucinations without ever having had auditory hallucinations. In the Irish and 
Australian samples, 30% and 37% and of patients with lifetime auditory hallucinations 
respectively had experienced visual hallucinations, whereas 83% and 97% of patients with 
lifetime visual hallucinations respectively had experienced auditory hallucinations (Table 5).  
INSERT-TABLE-5-ABOUT-HERE 
 
4. Discussion 
This study aimed to document lifetime and point prevalence of hallucinations by modality, as 
well as the extent to which hallucinations in different modalities co-occurred, in people 
diagnosed with schizophrenia-spectrum disorders. In terms of lifetime prevalence, a broad 
pattern emerged of auditory hallucinations being 2-3-fold more common than visual 
hallucinations, which in turn were around twice as common as tactile hallucinations, which in 
turn were around twice as common as olfactory hallucinations. This was consistent with the 
cross-cultural findings of Thomas et al. (2007), except for our finding of an excess of tactile 
over olfactory hallucinations, two modalities which Thomas et al. found to occur with a 
comparable prevalence. Whereas research into the prevalence of hallucinations has often 
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focussed on lifetime prevalence, our study was able to offer insights into point prevalence. 
Hallucinations had been experienced in the past month by about a quarter of each sample, 
predominantly in the auditory modality. Prevalence of hallucinations in the past month in the 
visual, olfactory, and tactile modalities were much lower (<10%). Patients’ reports also 
suggested visual hallucinations were often fleeting, transitory phenomena, compared to more 
chronic experiences of auditory hallucinations. This was consistent with Gauntlett-Gilbert 
and Kuipers’ (2003) finding that 40% of their sample (a majority of whom had 
schizophrenia-spectrum diagnoses) had only experienced visions between one and three 
times, 45% had experiences of visions spanning a period of 2 weeks or less, and only 15% 
described their visions as constant. The clearly graded hallucination-hierarchy by modality 
found for lifetime prevalence (auditory > visual > tactile > olfactory) was less clearly 
discernable for present experiences, which emerged as more of a two-tier hierarchy (auditory 
and others).  
In terms of associations between modalities, the majority of patients had only ever 
hallucinated in one modality, typically the auditory. Similarly, current hallucinatory 
experiences were uni-modal for the majority of patients, with 90% of these being in the 
auditory modality. When hallucinations in two different modalities co-occurred, auditory and 
visual hallucinations were the most common combination. When we further probed the 
relation between auditory and visual hallucinations, we found that only around a third of 
patients who had experienced auditory hallucinations had also experienced visual 
hallucinations, yet an overwhelming majority of patients who had experienced visual 
hallucinations had also experienced auditory hallucinations. This highlights the limited utility 
of a modality-independent hallucination mechanism (David, 2004), and reinforces the need to 
understand the reason for this pattern of co-occurrence. 
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The common co-occurrence of auditory and visual hallucinations suggests a different 
mechanism may be involved in visual hallucinations in schizophrenia than in 
neurodegenerative disorders (e.g., Lewy Body Dementia, Parkinson’s Disease), as the latter 
are not typically related to the presence of auditory hallucinations (Inzelberg et al., 1998), 
whereas the former nearly always are. However, there have been reports of anticholinergic 
medications being effective for visual hallucinations in people diagnosed with schizophrenia 
who were refractory to antipsychotic treatment (Patel et al., 2010). This suggests there may be 
multiple mechanisms underpinning visual hallucinations in people diagnosed with 
schizophrenia, as has previously been argued to be the case for auditory hallucinations 
(McCarthy-Jones et al., 2014). 
Lifetime rates of visual hallucinations, being 23% in the Irish sample and 31% in the 
Australian sample, were comparable with the mean visual hallucinations prevalence of 27% 
reported by Waters et al.’s (2014) recent review. Many of the visual hallucinations in the 
Irish sample were religious in nature, highlighting the potential effects of culture on the 
content of hallucinations (Larøi et al., 2014). We found no consistent association between 
visual hallucinations (or indeed, any modality of hallucination) and either age or gender. 
Previous studies have also reported mixed findings (Baethge et al., 2005; Bauer et al., 2011; 
Tien, 1991; Goodwin et al., 1971). Although visual hallucinations occurred at a lower 
prevalence than auditory hallucinations, and for many patients were a memory rather than a 
current phenomenon, they are often distressing (Dudley et al., 2012) and, at present, there is 
no evidence base supporting specific interventions for visual hallucinations in psychosis 
(Wilson et al., 2015). Further research examining the efficacy of novel treatments for visual 
hallucinations is required (Wilson et al., 2015). 
 Having provided further evidence of the nature of the distributions of hallucinations 
by modality, there is now a need to explain this. Whilst we are not able to provide clear 
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answers to this, we highlight how explanations could be proffered at multiple levels. 
Consider, for example, the excess of auditory over visual hallucinations. At the biological 
level, a cause may be sought in a greater degree of disruption to auditory (temporal) than 
visual (occipital) processing areas of the brain in those diagnosed with schizophrenia. There 
is some evidence of this. In terms of structural changes, a meta-analysis of over 18,000 
patients, Haijma et al. (2013) found greater reductions in grey matter volumes in the temporal 
lobe (Cohen’s d= 0.43) than the occipital lobe (d= 0.22). Similarly, studies of anti-psychotic 
naïve and first episode patients (Chan et al., 2011; Fusar-Poli et al., 2011), as well as studies 
of children at high risk of developing schizophrenia (Cullen et al., 2012) have found grey 
matter changes in temporal regions but not in other areas of sensory cortex. These structural 
changes are accompanied by functional changes. For example, grey matter reductions in the 
left superior temporal gyrus are associated with reductions in the auditory P300 event-related 
potential (McCarley et al., 1993). Similarly, functional changes detected by EEG studies of 
resting state activity have offered clearer evidence for abnormalities in the temporal lobe than 
in the occipital lobe (Mientus et al., 2002; Pascual-Marqui et al., 1999). Indeed, the 
characterisation of schizophrenia as predominantly a fronto-temporal disorder is consistent 
with phenomenological parallels with fronto-temporal dementia (Harciarek et al., 2013) and 
with Kraepelin’s (1919) original conception of this disorder. 
At the neurocognitive level, explanations could be sought within a predictive coding 
framework (Clark, 2013). For example, audition may be more amenable to the top-down 
effects of expectation than vision, or individuals may be more likely to find themselves 
without auditory input than visual input, potentially creating more fertile conditions for top-
down influences on audition than vision. Another possibility is that hallucinations in 
schizophrenia are aberrant forms of social communications (Wilkinson and Bell, 2016), and 
given the primary role of language in social communication (Fedurek and Slocombe, 2011), 
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this may explain the excess of auditory over visual hallucinations. Similarly, models of 
schizophrenia that view it as a breakdown of the self (Sass and Parnas, 2003), could be taken 
to predict a primacy of auditory over visual hallucinations due to the greater role of 
speech/language than visual imagery in the construction of the self. Finally, whilst early 
trauma is associated with hallucinations in both the auditory (Bentall et al., 2012) and visual 
(Solesvik et al., 2016) modalities, intrusive visual experiences are more commonly 
recognised as a re-experiencing symptom of PTSD than intrusive auditory experiences 
(McCarthy-Jones and Longden, 2015). This could lead individuals with visual hallucinations 
to be more likely to be diagnosed with PTSD than schizophrenia, leaving an excess of 
auditory over visual hallucinations in people diagnosed with schizophrenia. 
The hallucination-hierarchy in schizophrenia may be specific to this disorder. When 
standardised interviews (rather than self-report methods) assess the prevalence of 
hallucinations in the general population by modality, visual hallucinations are more 
commonly reported than auditory hallucinations (Tien, 1991; Sidgwick et al., 1894; Kessler 
et al., 2005). This highlights that hallucinations in schizophrenia do not represent a simple 
across the board inflation of prevalence of hallucinations in the general population, but rather 
a particular excess of auditory hallucinations. Future research should attempt to explain why 
there are such differing patterns in hallucination prevalence in these populations.  
This study had a number of limitations. First, different hallucination assessment tools 
were employed in our two samples. Yet, whilst variation in prevalence between groups may 
be at least partly attributable to this (or many other factors, as noted above), our study 
focussed on within-group differences in hallucination prevalence by modality, which were 
comparable between the two samples. Second, it was not possible, for people who reported 
hallucinations in more than one modality (e.g., auditory and visual hallucinations), to 
determine if the person experienced a vision talking to them or if they saw visions and heard 
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voices independently from this. Thus, it was not possible to know the extent to which the co-
occurrence of auditory and visual hallucinations represented a multimodal hallucinatory 
experience (Hoffman and Varanko, 2006) or their co-incidence. Third, we do not know under 
what conditions these experiences happened; past hallucinations could have occurred outside 
of the context of a psychotic illness, due to drug intoxication, sleep problems, or have been 
the type of hallucinatory experiences sometimes found in the general population (Blom and 
Sommer, 2012). Finally, interview-based prevalence assessments may create biases in 
responding. For example, the hallucination-hierarchy found here for current hallucinations, 
differed notably to that found by ESM studies (Delespaul and van Os, 2012; Oorschot et al., 
2012). The reasons for this difference remain to be explained, but may be based in fleeting 
visual hallucinations being less readily recalled in interview-based studies. 
 In conclusion, although needing replication from studies with alternative 
methodologies, such as ESM, the findings reported here help clarify the distribution of 
hallucinations by modality, and provide an explanatory target for theoretical models of this 
experience. 
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Table 1 
Demographic and clinical characteristics of samples 
 
Variable (mean, SD) 
Ireland 
(N=693) 
Australia 
(N=218) 
Comparison 
Age (years) 44.09 (13.49) 38.72 (11.00) t(909)=5.35, p<0.001 
Gender (% male) 70.3% 65.0% χ(1)=3.74, p=0.05 
Illness duration (years) 20.40 (13.51) a 15.70 (10.46) t(852)=4.68, p<0.001 
Diagnoses    
Schizophrenia 82.5% 74.3%  
χ(2)=7.55, p=0.02 Schizoaffective  16.9% 25.2% 
Schizophreniform 0.6% 0.5% 
a = Due to missing data, n=636.
  HALLUCINATIONS IN SCHIZOPHRENIA      27 
  
Table 2 
Prevalence of hallucinations by modality 
 Lifetime  Current (past month) 
Modality Ireland 
(n=205) 
Australia 
(n=218) 
 Ireland 
(n=693) 
Australia 
(n=218) 
Any hallucination 69.3% 81.7%  26.1% b 28.9% 
Auditory 63.9% 79.8%  23.2% c 27.1% 
Visual 22.9% 30.7%  4.6% d 8.3% 
Olfactory 5.8% a 9.6%  1.6% e 2.3% 
Tactile 9.3% 19.3%  3.7% d 6.9% 
a n = 206, b n=674; c n=682; d n=679; e n=676. 
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Table 3 
Co-occurrence of lifetime experiences of hallucinations by modality  
 Number of lifetime hallucination modalities 
 0 1 2 3 4 
 Ire Aus Ire Aus Ire Aus Ire Aus Ire Aus 
Number of patients 63 40 88 92 39 59 9 14 3 13 
% of all hallucinating patients - - 63.3%  51.7% 28.1%  33.1% 6.5% 7.9% 2.2% 7.3% 
Modalities of hallucinations 
Auditory 
 
- 
 
- 
 
89.8%  
 
95.6% 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
Visual - -   6.8%   2.2% - - - - - - 
Tactile - -   2.3%   2.2% - - - - - - 
Olfactory - -   1.1%   0.0% - - - - - - 
Auditory + visual - - - - 66.7% 66.1% - - - - 
Auditory + tactile - - - - 17.9% 22.0% - - - - 
Auditory + olfactory - - - - 10.3% 45.8% - - - - 
Visual + tactile - - - -   2.6%    0.0% - - - - 
Visual + olfactory - - - -   2.6%   0.0% - - - - 
Auditory + visual + tactile - - - - - - 66.7% 92.9% - - 
Auditory + visual + olfactory - - - - - - 33.3%  0.0% - - 
Auditory + olfactory + tactile - - - - - -   0.0% 7.1% - - 
Note. Ire = Irish sample. Aus  = Australian sample. Due to missing data, N(Irish sample) = 202.  
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Table 4 
Co-occurrence of current hallucinations (past month) by modality  
 Number of current hallucination modalities 
 0 1 2 3 4 
 Ire Aus Ire Aus Ire Aus Ire Aus Ire Aus 
Number of patients 498 155 133 37 29 21 9 2 0 3 
% of all hallucinating patients - - 77.8% 58.7% 17.0% 33.3% 5.3% 3.2% 0.0% 4.8% 
Modalities of hallucinations 
Auditory 
 
- 
 
- 
 
90.2% 
 
89.2% 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
Visual - - 3.8% 2.7% - - - - - - 
Tactile - - 5.3% 8.1% - - - - - - 
Olfactory - - 0.7% 0.0% - - - - - - 
Auditory + visual - - - - 41.4% 57.1% - - - - 
Auditory + tactile - - - - 24.1% 33.3% - - - - 
Auditory + olfactory - - - - 20.7% 9.5% - - - - 
Visual + tactile - - - - 10.3% 0.0% - - - - 
Visual + olfactory - - - - 3.4% 0.0% - - - - 
Auditory + visual + tactile - - - - - - 66.7% 100.0% - - 
Auditory + visual + olfactory - - - - - - 11.1% 0.0% - - 
Auditory + olfactory + tactile - - - - - - 11.1% 0.0% - - 
Visual + tactile + olfactory - - - - - - 11.1% 0.0% - - 
Note. Due to missing data, N(Irish sample) = 669, of which 171 experienced hallucinations.
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Table 5 
Associations between lifetime presence of auditory and visual hallucinations.  
 Never had 
visual 
hallucinations 
Lifetime 
visual 
hallucinations 
Association 
Ireland    
Never had auditory hallucinations 66 8 χ(1)=9.97, p=0.002 
Lifetime auditory hallucinations 90 39 
 
Australia  
   
Never had auditory hallucinations 42 2 χ(1)=17.76, 
p<0.001 
Lifetime auditory hallucinations 109 65  
Note. Due to missing data, N(Irish sample) = 203. 
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Figure 1 
Co-occurrence of current hallucinations by modality in Irish sample 
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